Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alfred E Buxton, M.D.

Title
Institution
Department
Address
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01HL045700 (BUXTON, ALFRED E) Sep 30, 1991 - Feb 29, 2000
    NIH/NHLBI
    NONSUSTAINED VENTRICULAR TACHYCARDIA
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Barkagan M, Rottmann M, Leshem E, Shen C, Buxton AE, Anter E. Effect of Baseline Impedance on Ablation Lesion Dimensions. Circ Arrhythm Electrophysiol. 2018 Oct; 11(10):e006690. PMID: 30354405.
    View in: PubMed
  2. Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018 09 27; 379(13):1205-1215. PMID: 30280654.
    View in: PubMed
  3. Huikuri H, Buxton AE. Identification of suitable patients for ICD therapy. Int J Cardiol. 2018 Dec 01; 272:217-218. PMID: 30131232.
    View in: PubMed
  4. Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Noseworthy PA, Hodge DO, Lushinsky EC, Mulholland MB, Cha YM, Gersh BJ, Madhavan M. Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement. Circ Arrhythm Electrophysiol. 2018 Aug; 11(8):e006155. PMID: 30354311.
    View in: PubMed
  5. Anter E, Duytschaever M, Shen C, Strisciuglio T, Leshem E, Contreras-Valdes FM, Waks JW, Zimetbaum PJ, Kumar K, Spector PS, Lee A, Gerstenfeld EP, Nakar E, Bar-Tal M, Buxton AE. Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias. Circ Arrhythm Electrophysiol. 2018 Aug; 11(8):e006536. PMID: 30354312.
    View in: PubMed
  6. Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA. 2018 07 03; 320(1):63-71. PMID: 29971398.
    View in: PubMed
  7. Anter E, Kleber AG, Rottmann M, Leshem E, Barkagan M, Tschabrunn CM, Contreras-Valdes FM, Buxton AE. Infarct-Related Ventricular Tachycardia: Redefining the Electrophysiological Substrate of the Isthmus During Sinus Rhythm. JACC Clin Electrophysiol. 2018 Aug; 4(8):1033-1048. PMID: 30139485.
    View in: PubMed
  8. Barkagan M, Contreras-Valdes FM, Leshem E, Buxton AE, Nakagawa H, Anter E. High-power and short-duration ablation for pulmonary vein isolation: Safety, efficacy, and long-term durability. J Cardiovasc Electrophysiol. 2018 Sep; 29(9):1287-1296. PMID: 29846987.
    View in: PubMed
  9. Malik M, Buxton AE, Huikuri H, Lombardi F, Schmidt G, Zabel M. Noninvasive electrophysiology in risk assessment and screening. Heart Rhythm. 2018 06; 15(6):803-804. PMID: 29857851.
    View in: PubMed
  10. Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes. Eur J Heart Fail. 2018 Jun; 20(6):1031-1038. PMID: 29761861.
    View in: PubMed
  11. Tereshchenko LG, Sotoodehnia N, Sitlani CM, Ashar FN, Kabir M, Biggs ML, Morley MP, Waks JW, Soliman EZ, Buxton AE, Biering-Sørensen T, Solomon SD, Post WS, Cappola TP, Siscovick DS, Arking DE. Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study). J Am Heart Assoc. 2018 Apr 05; 7(8). PMID: 29622589.
    View in: PubMed
  12. Biering-Sørensen T, Kabir M, Waks JW, Thomas J, Post WS, Soliman EZ, Buxton AE, Shah AM, Solomon SD, Tereshchenko LG. Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2018 Mar; 11(3):e005961. PMID: 29496680.
    View in: PubMed
  13. Waks JW, Buxton AE. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction. Annu Rev Med. 2018 Jan 29; 69:147-164. PMID: 29414264.
    View in: PubMed
  14. Adabag S, Patton KK, Buxton AE. Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply. JAMA Cardiol. 2017 Dec 01; 2(12):1397-1398. PMID: 28973098.
    View in: PubMed
  15. Anter E, Di Biase L, Contreras-Valdes FM, Gianni C, Mohanty S, Tschabrunn CM, Viles-Gonzalez JF, Leshem E, Buxton AE, Kulbak G, Halaby RN, Zimetbaum PJ, Waks JW, Thomas RJ, Natale A, Josephson ME. Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea. Circ Arrhythm Electrophysiol. 2017 Nov; 10(11). PMID: 29133380.
    View in: PubMed
  16. Sroubek J, Buxton AE. Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned? Card Electrophysiol Clin. 2017 12; 9(4):761-773. PMID: 29173416.
    View in: PubMed
  17. Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol. 2017 Nov; 28(11):1345-1351. PMID: 28744959.
    View in: PubMed
  18. Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 Jul 01; 2(7):767-774. PMID: 28724134.
    View in: PubMed
  19. Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. Am Heart J. 2017 Sep; 191:21-29. PMID: 28888266.
    View in: PubMed
  20. Shenasa M, Miller JM, Callans DJ, Almendral JM, Marchlinski FE, Buxton AE. Conquest of Ventricular Tachycardia: Insights Into Mechanisms, Innovations in Management: Contribution of Mark E. Josephson, MD, to Clinical Electrophysiology. Circ Arrhythm Electrophysiol. 2017 May; 10(5). PMID: 28487348.
    View in: PubMed
  21. Buxton A. "What Would He Do Next?" Arrhythm Electrophysiol Rev. 2017 Apr; 6(1):13. PMID: 28507739.
    View in: PubMed
  22. Buxton AE. Sudden death in ischemic heart disease - 2017. Int J Cardiol. 2017 Jun 15; 237:64-66. PMID: 28365181.
    View in: PubMed
  23. Katritsis DG, Marine JE, Contreras FM, Fujii A, Latchamsetty R, Siontis KC, Katritsis GD, Zografos T, John RM, Epstein LM, Michaud GF, Anter E, Sepahpour A, Rowland E, Buxton AE, Calkins H, Morady F, Stevenson WG, Josephson ME. Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia. Circulation. 2016 Nov 22; 134(21):1655-1663. PMID: 27754882.
    View in: PubMed
  24. Buxton AE, Waks JW, Shen C, Chen PS. Risk stratification for sudden cardiac death in North America - current perspectives. J Electrocardiol. 2016 Nov - Dec; 49(6):817-823. PMID: 27524476.
    View in: PubMed
  25. Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit. Circulation. 2016 Jul 26; 134(4):314-27. PMID: 27440005.
    View in: PubMed
  26. Shen C, Hu Y, Li X, Wang Y, Chen PS, Buxton AE. Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree. Biom J. 2016 Nov; 58(6):1357-1375. PMID: 27356196.
    View in: PubMed
  27. Waks JW, Sitlani CM, Soliman EZ, Kabir M, Ghafoori E, Biggs ML, Henrikson CA, Sotoodehnia N, Biering-Sørensen T, Agarwal SK, Siscovick DS, Post WS, Solomon SD, Buxton AE, Josephson ME, Tereshchenko LG. Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Circulation. 2016 Jun 07; 133(23):2222-34. PMID: 27081116; PMCID: PMC4899170 [Available on 06/07/17].
  28. Brooks GC, Lee BK, Rao R, Lin F, Morin DP, Zweibel SL, Buxton AE, Pletcher MJ, Vittinghoff E, Olgin JE. Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study. J Am Coll Cardiol. 2016 Mar 15; 67(10):1186-1196. PMID: 26965540.
    View in: PubMed
  29. Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2016 Mar; 9(3):e003283. PMID: 26921377; PMCID: PMC4998185.
  30. Serber ER, Fava JL, Christon LM, Buxton AE, Goldberger JJ, Gold MR, Rodrigue JR, Frisch MB. Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway. Pacing Clin Electrophysiol. 2016 May; 39(5):458-70. PMID: 26813033; PMCID: PMC4846522 [Available on 05/01/17].
  31. Levine YC, Matos J, Rosenberg MA, Manning WJ, Josephson ME, Buxton AE. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy. Heart Rhythm. 2016 Feb; 13(2):490-7. PMID: 26409099.
    View in: PubMed
  32. Shvilkin A, Ellis ER, Gervino EV, Litvak AD, Buxton AE, Josephson ME. Painful left bundle branch block syndrome: Clinical and electrocardiographic features and further directions for evaluation and treatment. Heart Rhythm. 2016 Jan; 13(1):226-32. PMID: 26331973.
    View in: PubMed
  33. Huang HD, Waks JW, Contreras-Valdes FM, Haffajee C, Buxton AE, Josephson ME. Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter. Europace. 2016 Apr; 18(4):521-30. PMID: 26311563.
    View in: PubMed
  34. Sciammarella MG, Gerson M, Buxton AE, Bartley SC, Doukky R, Merlino DA, Tandon S, Thompson R, Travin MI. ASNC/SNMMI Model Coverage Policy: Myocardial sympathetic innervation imaging: Iodine-123 meta-iodobenzylguanidine ((123)I-mIBG). J Nucl Cardiol. 2015 Aug; 22(4):804-11. PMID: 26163203.
    View in: PubMed
  35. Tschabrunn CM, Roujol S, Nezafat R, Faulkner-Jones B, Buxton AE, Josephson ME, Anter E. A swine model of infarct-related reentrant ventricular tachycardia: Electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm. 2016 Jan; 13(1):262-73. PMID: 26226214; PMCID: PMC4747106.
  36. Katritsis DG, Marine JE, Latchamsetty R, Zografos T, Tanawuttiwat T, Sheldon SH, Buxton AE, Calkins H, Morady F, Josephson ME. Coexistent Types of Atrioventricular Nodal Re-Entrant Tachycardia: Implications for the Tachycardia Circuit. Circ Arrhythm Electrophysiol. 2015 Oct; 8(5):1189-93. PMID: 26155802; PMCID: PMC4608481.
  37. Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):437-46. PMID: 26038525; PMCID: PMC4512855.
  38. Contreras-Valdes FM, Buxton AE, Josephson ME, Anter E. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors. J Am Coll Cardiol. 2015 Apr 14; 65(14):1485-7. PMID: 25857916.
    View in: PubMed
  39. Tschabrunn CM, Silverstein J, Berzin T, Ellis E, Buxton AE, Josephson ME, Anter E. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015 Jun; 17(6):891-7. PMID: 25777771.
    View in: PubMed
  40. Levine YC, Tuttle MK, Rosenberg MA, Goldberg R, Matos J, Samuel M, Kramer DB, Buxton AE. Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines. Am J Cardiol. 2015 Jun 01; 115(11):1539-44. PMID: 25840578; PMCID: PMC4433567.
  41. Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):179-86. PMID: 25669833; PMCID: PMC4408540.
  42. Waks JW, Higgins AY, Mittleman MA, Buxton AE. Influence of renal function on mortality and ventricular arrhythmias in patients undergoing first implantable cardioverter-defibrillator generator replacement. J Cardiovasc Electrophysiol. 2015 Mar; 26(3):282-90. PMID: 25431143; PMCID: PMC4741276.
  43. Buxton AE, Wilde AA, Chen PS. A new ECG section in HeartRhythm by Josephson and Wellens. Heart Rhythm. 2014 Dec; 11(12):2328. PMID: 25454059.
    View in: PubMed
  44. Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LY, Sanders GD. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. JACC Heart Fail. 2014 Dec; 2(6):623-9. PMID: 25306452.
    View in: PubMed
  45. Anter E, Silverstein J, Tschabrunn CM, Shvilkin A, Haffajee CI, Zimetbaum PJ, Buxton AE, Josephson ME, Gelfand E, Manning WJ. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014 Nov; 11(11):1890-7. PMID: 25034183.
    View in: PubMed
  46. Levine YC, Rosenberg MA, Mittleman M, Samuel M, Methachittiphan N, Link M, Josephson ME, Buxton AE. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. Heart Rhythm. 2014 Jul; 11(7):1109-16. PMID: 24837348.
    View in: PubMed
  47. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Warner Stevenson L, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303. PMID: 24819194.
    View in: PubMed
  48. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014 Jul 01; 130(1):94-125. PMID: 24815500.
    View in: PubMed
  49. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014 Sep 16; 64(11):1143-77. PMID: 24820349.
    View in: PubMed
  50. Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kääb S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014 Jul 01; 35(25):1642-51. PMID: 24801071; PMCID: PMC4076664.
  51. Warraich HJ, Buxton AE, Kociol RD. Macroscopic T-wave alternans in a patient with takotsubo cardiomyopathy and QT prolongation. Heart Rhythm. 2014 Oct; 11(10):1848-9. PMID: 24607719.
    View in: PubMed
  52. Anter E, Tschabrunn CM, Contreras-Valdes FM, Buxton AE, Josephson ME. Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation. Heart Rhythm. 2014 May; 11(5):783-90. PMID: 24583098.
    View in: PubMed
  53. Hoang A, Shen C, Zheng J, Taylor S, Groh WJ, Rosenman M, Buxton AE, Chen PS. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55. PMID: 24566233; PMCID: PMC4074531.
  54. Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014 Jul; 64(1):32-9. PMID: 24518128; PMCID: PMC4383404.
  55. Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014 Feb; 11(2):216-21. PMID: 24513917; PMCID: PMC4001927.
  56. Goldberger JJ, Basu A, Boineau R, Buxton AE, Cain ME, Canty JM, Chen PS, Chugh SS, Costantini O, Exner DV, Kadish AH, Lee B, Lloyd-Jones D, Moss AJ, Myerburg RJ, Olgin JE, Passman R, Stevenson WG, Tomaselli GF, Zareba W, Zipes DP, Zoloth L. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014 Jan 28; 129(4):516-26. PMID: 24470473.
    View in: PubMed
  57. Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders GD. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? Int J Cardiol. 2014 Mar 01; 172(1):253-4. PMID: 24467982.
    View in: PubMed
  58. Buxton AE. Programmed ventricular stimulation: not dead. Circulation. 2014 Feb 25; 129(8):831-3. PMID: 24381210.
    View in: PubMed
  59. Rosenberg MA, Lopez FL, Bužková P, Adabag S, Chen LY, Sotoodehnia N, Kronmal RA, Siscovick DS, Alonso A, Buxton A, Folsom AR, Mukamal KJ. Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ann Epidemiol. 2014 Mar; 24(3):174-179.e2. PMID: 24360853.
    View in: PubMed
  60. Shen C, Jeong J, Li X, Chen PS, Buxton A. Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect. Biometrics. 2013 Sep; 69(3):724-31. PMID: 23865447; PMCID: PMC3787989.
  61. Goldberger JJ, Buxton AE. Personalized medicine vs guideline-based medicine. JAMA. 2013 Jun 26; 309(24):2559-60. PMID: 23712449.
    View in: PubMed
  62. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):488-97. PMID: 23759471; PMCID: PMC3839636.
  63. Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23; 62(4):300-5. PMID: 23623910.
    View in: PubMed
  64. Rayatzadeh H, Tan A, Chan RH, Patel SJ, Hauser TH, Ngo L, Shaw JL, Hong SN, Zimetbaum P, Buxton AE, Josephson ME, Manning WJ, Nezafat R. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy. J Cardiovasc Magn Reson. 2013 Apr 10; 15:31. PMID: 23574733; PMCID: PMC3750752.
  65. Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LY, Sanders GD. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm. 2013 Jun; 10(6):828-35. PMID: 23416381.
    View in: PubMed
  66. Rayatzadeh H, Patel SJ, Hauser TH, Ngo LL, Shaw JL, Tan A, Buxton AE, Zimetbaum P, Josephson ME, Appelbaum E, Manning WJ, Nezafat R. Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratification of patients for primary prevention implantable cardioverter-defibrillator implantation. Am J Cardiol. 2013 Apr 15; 111(8):1175-9. PMID: 23375599; PMCID: PMC3619203.
  67. Buxton AE. Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit. J Am Coll Cardiol. 2012 Oct 23; 60(17):1656-8. PMID: 23021332.
    View in: PubMed
  68. Anter E, Buxton AE, Silverstein JR, Josephson ME. Idiopathic ventricular fibrillation originating from the moderator band. J Cardiovasc Electrophysiol. 2013 Jan; 24(1):97-100. PMID: 22882745.
    View in: PubMed
  69. Tan AY, Abdi S, Buxton AE, Anter E. Percutaneous stellate ganglia block for acute control of refractory ventricular tachycardia. Heart Rhythm. 2012 Dec; 9(12):2063-7. PMID: 22863887.
    View in: PubMed
  70. Cheng A, Wang Y, Berger RD, Calkins H, Buxton AE, Curtis JP, Lampert R. Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®. Pacing Clin Electrophysiol. 2012 Aug; 35(8):912-8. PMID: 22670627.
    View in: PubMed
  71. Kramer DB, Buxton AE, Zimetbaum PJ. Time for a change--a new approach to ICD replacement. N Engl J Med. 2012 Jan 26; 366(4):291-3. PMID: 22276818.
    View in: PubMed
  72. Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Arch Intern Med. 2012 Jan 09; 172(1):64-7. PMID: 22082711.
    View in: PubMed
  73. Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2011 Sep 27; 58(14):1517-38. PMID: 21880456.
    View in: PubMed
  74. Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Circulation. 2011 Sep 27; 124(13):1483-502. PMID: 21875906.
    View in: PubMed
  75. Wadehra V, Buxton AE, Antoniadis AP, McCready JW, Redpath CJ, Segal OR, Rowland E, Lowe MD, Lambiase PD, Chow AW. The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace. 2011 Oct; 13(10):1401-5. PMID: 21828065.
    View in: PubMed
  76. Weintraub WS, Karlsberg RP, Tcheng JE, Boris JR, Buxton AE, Dove JT, Fonarow GC, Goldberg LR, Heidenreich P, Hendel RC, Jacobs AK, Lewis W, Mirro MJ, Shahian DM. ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2011 Jul 05; 58(2):202-22. PMID: 21652161.
    View in: PubMed
  77. Weintraub WS, Karlsberg RP, Tcheng JE, Boris JR, Buxton AE, Dove JT, Fonarow GC, Goldberg LR, Heidenreich P, Hendel RC, Jacobs AK, Lewis W, Mirro MJ, Shahian DM, Hendel RC, Bozkurt B, Jacobs JP, Peterson PN, Roger VL, Smith EE, Tcheng JE, Wang T. ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. Circulation. 2011 Jul 05; 124(1):103-23. PMID: 21646493.
    View in: PubMed
  78. Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP, Lloyd-Jones D, Kadish AH, Lee B, Moss A, Myerburg R, Olgin J, Passman R, Rosenbaum D, Stevenson W, Zareba W, Zipes DP. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation. 2011 May 31; 123(21):2423-30. PMID: 21632516.
    View in: PubMed
  79. Buxton AE. Sudden cardiac death won't go away: what are we to do? Heart Rhythm. 2011 Aug; 8(8):1183-4. PMID: 21699829.
    View in: PubMed
  80. Lorvidhaya P, Addo K, Chodosh A, Iyer V, Lum J, Buxton AE. Sudden cardiac death risk stratification in patients with heart failure. Heart Fail Clin. 2011 Apr; 7(2):157-74, vii. PMID: 21439495.
    View in: PubMed
  81. Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen PS, Estes M, Jouven X, Kwong R, Lathrop DA, Mascette AM, Nerbonne JM, O'Rourke B, Page RL, Roden DM, Rosenbaum DS, Sotoodehnia N, Trayanova NA, Zheng ZJ. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010 Nov 30; 122(22):2335-48. PMID: 21147730.
    View in: PubMed
  82. AlMahameed ST, Buxton AE, Michaud GF. New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):578-84. PMID: 20971759.
    View in: PubMed
  83. Buxton AE. Implantable loop recorder in survivors of acute myocardial infarction: a glimpse of reality? Circulation. 2010 Sep 28; 122(13):1255-7. PMID: 20837889.
    View in: PubMed
  84. Mellion ML, Buxton AE, Iyer V, Almahameed S, Lorvidhaya P, Gilchrist JM. Safety of nerve conduction studies in patients with peripheral intravenous lines. Muscle Nerve. 2010 Aug; 42(2):189-91. PMID: 20658600.
    View in: PubMed
  85. Al-Khatib SM, Hafley G, Lee KL, Buxton AE. Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace. 2010 Aug; 12(8):1112-8. PMID: 20452992; PMCID: PMC2910601.
  86. Buxton AE, Ellison KE, Lorvidhaya P, Ziv O. Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation. J Cardiovasc Pharmacol. 2010 May; 55(5):450-5. PMID: 20509178.
    View in: PubMed
  87. Piccini JP, Al-Khatib SM, Myers ER, Anstrom KJ, Buxton AE, Peterson ED, Sanders GD. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis. J Cardiovasc Electrophysiol. 2010 Jul; 21(7):791-8. PMID: 20132397.
    View in: PubMed
  88. Ziv O, Morales E, Song YK, Peng X, Odening KE, Buxton AE, Karma A, Koren G, Choi BR. Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome. J Physiol. 2009 Oct 01; 587(Pt 19):4661-80. PMID: 19675070; PMCID: PMC2768020.
  89. Piccini JP, Hafley GE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Buxton AE. Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT). J Cardiovasc Electrophysiol. 2009 Aug; 20(8):850-5. PMID: 19490266.
    View in: PubMed
  90. Wilkoff BL, Kudenchuk PJ, Buxton AE, Sharma A, Cook JR, Bhandari AK, Biehl M, Tomassoni G, Leonen A, Klevan LR, Hallstrom AP. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol. 2009 Mar 10; 53(10):872-80. PMID: 19264245.
    View in: PubMed
  91. Buxton AE. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm. 2009 Jun; 6(6):836-47. PMID: 19467514.
    View in: PubMed
  92. Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, Knuuti J, Flotats A, Arrighi J, Muxi A, Alibelli MJ, Banerjee G, Jacobson AF. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008 Sep; 1(2):131-40. PMID: 19808530.
    View in: PubMed
  93. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008 Jun 19; 358(25):2667-77. PMID: 18565859.
    View in: PubMed
  94. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007 Sep 18; 50(12):1150-7. PMID: 17868806.
    View in: PubMed
  95. Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, Josephson ME, Zimetbaum P. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27; 167(15):1648-53. PMID: 17698688; PMCID: PMC2424189.
  96. Stanchina ML, Ellison K, Malhotra A, Anderson M, Kirk M, Benser ME, Tosi C, Carlisle C, Millman RP, Buxton A. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest. 2007 Aug; 132(2):433-9. PMID: 17573498; PMCID: PMC2287194.
  97. Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fain E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky M, Hohnloser S, Kim RJ, Lee K, Mark D, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J. 2007 Jun; 153(6):941-50. PMID: 17540194.
    View in: PubMed
  98. Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R. Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Am Heart J. 2007 Jun; 153(6):951-9. PMID: 17540195.
    View in: PubMed
  99. Fisher JD, Buxton AE, Lee KL, Packer DL, Echt DS, Denes P, Lehmann MH, DiMarco JP, Roy D, Hafley GE. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). Am J Cardiol. 2007 Jul 01; 100(1):76-83. PMID: 17599445; PMCID: PMC4733349.
  100. Ott P, Kirk MM, Koo C, He DS, Bhattacharya B, Buxton A. Coronary sinus and fossa ovalis ablation: effect on interatrial conduction and atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Mar; 18(3):310-7. PMID: 17257123.
    View in: PubMed
  101. Frain BH, Ellison KE, Michaud GF, Koo CH, Buxton AE, Kirk MM. True bipolar defibrillator leads have increased sensing latency and threshold compared with the integrated bipolar configuration. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):192-5. PMID: 17239139.
    View in: PubMed
  102. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, Poppas A, Prystowsky EN, Schoenfeld MH, Zimetbaum PJ, Heidenreich PA, Goff DC, Grover FL, Malenka DJ, Peterson ED, Radford MJ, Redberg RF. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). J Am Coll Cardiol. 2006 Dec 05; 48(11):2360-96. PMID: 17161282.
    View in: PubMed
  103. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. Rev Esp Cardiol. 2006 Dec; 59(12):1328. PMID: 17194428.
    View in: PubMed
  104. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, Poppas A, Prystowsky EN, Schoenfeld MH, Zimetbaum PJ, Goff DC, Grover FL, Malenka DJ, Peterson ED, Radford MJ, Redberg RF. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation. 2006 Dec 05; 114(23):2534-70. PMID: 17130345.
    View in: PubMed
  105. Buxton AE. Implantable cardioverter-defibrillators should be used routinely in the elderly. Am J Geriatr Cardiol. 2006 Nov-Dec; 15(6):361-4; quiz 365-6. PMID: 17086029.
    View in: PubMed
  106. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006 Sep 05; 48(5):e247-346. PMID: 16949478.
    View in: PubMed
  107. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006 Sep; 27(17):2099-140. PMID: 16923744.
    View in: PubMed
  108. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):746-837. PMID: 16935866.
    View in: PubMed
  109. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Sep 05; 114(10):e385-484. PMID: 16935995.
    View in: PubMed
  110. Buxton AE. Identifying the high risk patient with coronary artery disease--is ejection fraction all you need? J Cardiovasc Electrophysiol. 2005 Sep; 16 Suppl 1:S25-7. PMID: 16138881.
    View in: PubMed
  111. Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol. 2005 Jul 19; 46(2):310-6. PMID: 16022960.
    View in: PubMed
  112. Buxton AE. Sudden death after myocardial infarction--who needs prophylaxis, and when? N Engl J Med. 2005 Jun 23; 352(25):2638-40. PMID: 15972871.
    View in: PubMed
  113. Al-Khatib SM, Sanders GD, Mark DB, Lee KL, Bardy GH, Bigger JT, Buxton AE, Connolly S, Kadish A, Moss A, Feldman AM, Ellenbogen KA, Singh S, Califf RM. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J. 2005 Jun; 149(6):1020-34. PMID: 15976783.
    View in: PubMed
  114. Buxton AE. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation. 2005 May 17; 111(19):2537-49; discussion 2537-49. PMID: 15897357.
    View in: PubMed
  115. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol. 2004 Sep; 15(9):993-8. PMID: 15363069.
    View in: PubMed
  116. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004 Aug 17; 110(7):766-9. PMID: 15289365.
    View in: PubMed
  117. Buxton AE. Direct current cardioversion for atrial fibrillation and flutter. Med Health R I. 2004 Apr; 87(4):97. PMID: 15168632.
    View in: PubMed
  118. Buxton A. Acute management of atrial fibrillation. Med Health R I. 2004 Apr; 87(4):94-6. PMID: 15168631.
    View in: PubMed
  119. Buxton AE. Atrial fibrillation and flutter: overview. Med Health R I. 2004 Apr; 87(4):92-3. PMID: 15168630.
    View in: PubMed
  120. Buxton AE. Risk stratification for sudden death: do we need anything more than ejection fraction? Card Electrophysiol Rev. 2003 Dec; 7(4):434-7. PMID: 15071270.
    View in: PubMed
  121. Buxton AE, Ellison KE, Kirk MM, Frain B, Koo C, Gandhi G, Khouzam S. Primary prevention of sudden cardiac death: trials in patients with coronary artery disease. J Interv Card Electrophysiol. 2003 Oct; 9(2):203-6. PMID: 14574032.
    View in: PubMed
  122. Russo AM, Hafley GE, Lee KL, Stamato NJ, Lehmann MH, Page RL, Kus T, Buxton AE. Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. Circulation. 2003 Jul 08; 108(1):67-72. PMID: 12821551.
    View in: PubMed
  123. Buxton AE. The clinical use of implantable cardioverter defibrillators: where are we now? Where should we go? Ann Intern Med. 2003 Mar 18; 138(6):512-4. PMID: 12639087.
    View in: PubMed
  124. Nicholson WJ, Buxton AE, Tammaro D. Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. Clin Infect Dis. 2003 Feb 01; 36(3):e35-9. PMID: 12539087.
    View in: PubMed
  125. Buxton AE, Kirk MM, Michaud GF, Ellison KE, Nyren L. Management of the non-inducible patient. Card Electrophysiol Rev. 2002 Dec; 6(4):466-71. PMID: 12438830.
    View in: PubMed
  126. Ellison KE, Hafley GE, Hickey K, Kellen J, Coromilas J, Stein KM, Lee KL, Buxton AE. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). Circulation. 2002 Nov 19; 106(21):2694-9. PMID: 12438295.
    View in: PubMed
  127. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, Pires LA, Gold MR, Packer DL, Josephson ME, Prystowsky EN, Talajic MR. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation. 2002 Nov 05; 106(19):2466-72. PMID: 12417544.
    View in: PubMed
  128. Pires LA, Hafley GE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Buxton AE. Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction. J Cardiovasc Electrophysiol. 2002 Aug; 13(8):757-63. PMID: 12212692.
    View in: PubMed
  129. Lee KL, Hafley G, Fisher JD, Gold MR, Prystowsky EN, Talajic M, Josephson ME, Packer DL, Buxton AE. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation. 2002 Jul 09; 106(2):233-8. PMID: 12105164.
    View in: PubMed
  130. Kadish AH, Buxton AE, Kennedy HL, Knight BP, Mason JW, Schuger CD, Tracy CM, Winters WL, Boone AW, Elnicki M, Hirshfeld JW, Lorell BH, Rodgers GP, Tracy CM, Weitz HH. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: A report of the ACC/AHA/ACP-ASIM task force on clinical competence (ACC/AHA Committee to develop a clinical competence statement on electrocardiography and ambulatory electrocardiography) endorsed by the International Society for Holter and noninvasive electrocardiology. Circulation. 2001 Dec 18; 104(25):3169-78. PMID: 11748119.
    View in: PubMed
  131. Kadish AH, Buxton AE, Kennedy HL, Knight BP, Mason JW, Schuger CD, Tracy CM, Boone AW, Elnicki M, Hirshfeld JW, Lorell BH, Rodgers GP, Tracy CM, Weitz HH. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography. A report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography). J Am Coll Cardiol. 2001 Dec; 38(7):2091-100. PMID: 11738321.
    View in: PubMed
  132. Pires LA, Lehmann MH, Buxton AE, Hafley GE, Lee KL. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. J Am Coll Cardiol. 2001 Oct; 38(4):1156-62. PMID: 11583897.
    View in: PubMed
  133. Wyse DG, Talajic M, Hafley GE, Buxton AE, Mitchell LB, Kus TK, Packer DL, Kou WH, Lemery R, Santucci P, Grimes D, Hickey K, Stevens C, Singh SN. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol. 2001 Aug; 38(2):344-51. PMID: 11499722.
    View in: PubMed
  134. Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation. 2001 Jul 24; 104(4):436-41. PMID: 11468206.
    View in: PubMed
  135. Singh SN, Karasik P, Hafley GE, Pieper KS, Lee KL, Wyse DG, Buxton AE. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial. Am J Cardiol. 2001 Mar 15; 87(6):716-20. PMID: 11249889.
    View in: PubMed
  136. Weigner MJ, Buxton AE. Nonsustained ventricular tachycardia. A guide to the clinical significance and management. Med Clin North Am. 2001 Mar; 85(2):305-20, x. PMID: 11233950.
    View in: PubMed
  137. Buxton AE, Kirk MM, Michaud GF. Current approaches to evaluation and management of patients with ventricular arrhythmias. Med Health R I. 2001 Feb; 84(2):58-62. PMID: 11272662.
    View in: PubMed
  138. Josephson ME, Callans DJ, Buxton AE. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med. 2000 Dec 05; 133(11):901-10. PMID: 11103061.
    View in: PubMed
  139. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000 Jun 29; 342(26):1937-45. PMID: 10874061.
    View in: PubMed
  140. Buxton AE, Duc J, Berger EE, Torres V. Nonsustained ventricular tachycardia. Cardiol Clin. 2000 May; 18(2):327-36, viii. PMID: 10849876.
    View in: PubMed
  141. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999 Dec 16; 341(25):1882-90. PMID: 10601507.
    View in: PubMed
  142. Buxton AE, Hafley GE, Lehmann MH, Gold M, O'Toole M, Tang A, Coromilas J, Hook B, Stamato NJ, Lee KL. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation. 1999 Apr 13; 99(14):1843-50. PMID: 10199881.
    View in: PubMed
  143. Altemose GT, Buxton AE. Idiopathic ventricular tachycardia. Annu Rev Med. 1999; 50:159-77. PMID: 10073270.
    View in: PubMed
  144. Buxton AE. Programmed stimulation of the ventricles--back to the future. J Interv Card Electrophysiol. 1997 Dec; 1(4):281-5. PMID: 9869981.
    View in: PubMed
  145. Rothman SA, Hsia HH, Cossú SF, Chmielewski IL, Buxton AE, Miller JM. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation. 1997 Nov 18; 96(10):3499-508. PMID: 9396447.
    View in: PubMed
  146. Cossú SF, Rothman SA, Chmielewski IL, Hsia HH, Vogel RL, Miller JM, Buxton AE. The effects of isoproterenol on the cardiac conduction system: site-specific dose dependence. J Cardiovasc Electrophysiol. 1997 Aug; 8(8):847-53. PMID: 9261710.
    View in: PubMed
  147. Mason JW, Hancock EW, Saunders DE, Schuger CD, Griffin JC, Kennedy HL, Buxton AE, Mittal N. American College of Cardiology report on ECGEXAM. J Am Coll Cardiol. 1997 Feb; 29(2):466-8. PMID: 9015007.
    View in: PubMed
  148. Rothman SA, Jeevanandam V, Combs WG, Furukawa S, Hsia HH, Eisen HJ, Buxton AE, Miller JM. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation. 1996 Nov 01; 94(9 Suppl):II278-82. PMID: 8901760.
    View in: PubMed
  149. Miller JM, Cossú SF, Chmielewski IL, Hsia HH, Rothman SA, Vogel RL, Buxton AE. Primary ablation of atrial flutter and atrial fibrillation. Cardiol Clin. 1996 Nov; 14(4):569-90. PMID: 8950058.
    View in: PubMed
  150. Buxton AE, Josephson ME. For-profit health plans. N Engl J Med. 1996 Aug 08; 335(6):436; author reply 437-8. PMID: 8676943.
    View in: PubMed
  151. Buxton AE, Lee KL, DiCarlo L, Echt DS, Fisher JD, Greer GS, Josephson ME, Packer D, Prystowsky EN, Talajíc M. Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators. Ann Intern Med. 1996 Jul 01; 125(1):35-9. PMID: 8644986.
    View in: PubMed
  152. Sarter BH, Finkle JK, Gerszten RE, Buxton AE. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol. 1996 Jul; 28(1):122-9. PMID: 8752804.
    View in: PubMed
  153. Buxton AE. Ongoing risk stratification trials: the primary prevention of sudden death. Control Clin Trials. 1996 Jun; 17(3 Suppl):47S-51S. PMID: 8877267.
    View in: PubMed
  154. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol. 1996 Jan 25; 77(3):72A-82A. PMID: 8607395.
    View in: PubMed
  155. Rothman SA, Miller JM, Hsia HH, Buxton AE. Radiofrequency ablation of a supraventricular tachycardia due to interatrial conduction from the recipient to donor atria in an orthotopic heart transplant recipient. J Cardiovasc Electrophysiol. 1995 Jul; 6(7):544-50. PMID: 8528489.
    View in: PubMed
  156. Vaitkus PT, Miller JM, Buxton AE, Josephson ME, Laskey WK. Ischemia-induced changes in human endocardial electrograms during percutaneous transluminal coronary angioplasty. Am Heart J. 1994 Jun; 127(6):1481-90. PMID: 8197972.
    View in: PubMed
  157. Domanski MJ, Buxton AE. The primary prevention of sudden death in patients with coronary artery disease. Ann Intern Med. 1993 Dec 15; 119(12):1218-20. PMID: 8239255.
    View in: PubMed
  158. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, Simson MB, DiCarlo L, Echt DS, Packer D, et al. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis. 1993 Nov-Dec; 36(3):215-26. PMID: 8234775.
    View in: PubMed
  159. Mitra RL, Buxton AE. The clinical significance of nonsustained ventricular tachycardia. J Cardiovasc Electrophysiol. 1993 Aug; 4(4):490-6. PMID: 8269315.
    View in: PubMed
  160. Buxton AE, Kleiman RB, Kindwall KE, Josephson ME. Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia. Am J Cardiol. 1993 Mar 15; 71(8):695-8. PMID: 8447267.
    View in: PubMed
  161. Hsia HH, Buxton AE. Work-up and management of patients with sustained and nonsustained monomorphic ventricular tachycardias. Cardiol Clin. 1993 Feb; 11(1):21-37. PMID: 8435822.
    View in: PubMed
  162. Buxton AE, Josephson ME, Marchlinski FE, Miller JM. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. J Am Coll Cardiol. 1993 Jan; 21(1):90-8. PMID: 8417082.
    View in: PubMed
  163. Hook BG, Marchlinski FE, Josephson ME, Buxton AE. Effect of high-current stimulation in patients with sustained ventricular tachycardia rendered noninducible by antiarrhythmic drugs. Am J Cardiol. 1992 Sep 15; 70(7):752-7. PMID: 1519525.
    View in: PubMed
  164. Hook BG, Rosenthal ME, Marchlinski FE, Buxton AE, Josephson ME. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents. Pacing Clin Electrophysiol. 1992 Mar; 15(3):324-33. PMID: 1372727.
    View in: PubMed
  165. Buxton AE. Antiarrhythmic drugs: good for premature ventricular complexes but bad for patients? Ann Intern Med. 1992 Mar 01; 116(5):420-2. PMID: 1371042.
    View in: PubMed
  166. Vaitkus PT, Kindwall KE, Marchlinski FE, Miller JM, Buxton AE, Josephson ME. Differences in electrophysiological substrate in patients with coronary artery disease and cardiac arrest or ventricular tachycardia. Insights from endocardial mapping and signal-averaged electrocardiography. Circulation. 1991 Aug; 84(2):672-8. PMID: 1860211.
    View in: PubMed
  167. Buxton AE, Rosenthal ME, Marchlinski FE, Miller JM, Flores B, Josephson ME. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. Am J Cardiol. 1991 Apr 15; 67(9):835-42. PMID: 1707220.
    View in: PubMed
  168. Vaitkus PT, Kindwall KE, Miller JM, Marchlinski FE, Buxton AE, Josephson ME. Influence of gender on inducibility of ventricular arrhythmias in survivors of cardiac arrest with coronary artery disease. Am J Cardiol. 1991 Mar 01; 67(6):537-9. PMID: 1998288.
    View in: PubMed
  169. Vaitkus PT, Buxton AE, Josephson ME, Marchlinski FE. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. Am J Cardiol. 1990 Sep 15; 66(7):710-4. PMID: 2399887.
    View in: PubMed
  170. Buxton AE. Catheter ablation of atrioventricular bypass tracts. Still an investigational procedure. Circulation. 1989 Jun; 79(6):1388-90. PMID: 2720934.
    View in: PubMed
  171. Buxton AE, Marchlinski FE, Miller JM, Morrison DF, Frame LH, Josephson ME. The human atrial strength-interval relation. Influence of cycle length and procainamide. Circulation. 1989 Feb; 79(2):271-80. PMID: 2914346.
    View in: PubMed
  172. Kadish AH, Rosenthal ME, Vassallo JA, Cassidy DM, Buxton AE, Marchlinski FE, Miller JM, Josephson ME. Sinus mapping in patients with cardiac arrest and coronary disease--results and correlation with outcome. Pacing Clin Electrophysiol. 1989 Feb; 12(2):301-10. PMID: 2468140.
    View in: PubMed
  173. Marchlinski FE, Buxton AE, Josephson ME, Schmitt C. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration. Circulation. 1989 Jan; 79(1):39-46. PMID: 2910546.
    View in: PubMed
  174. Berger MD, Waxman HL, Buxton AE, Marchlinski FE, Josephson ME. Spontaneous compared with induced onset of sustained ventricular tachycardia. Circulation. 1988 Oct; 78(4):885-92. PMID: 3168197.
    View in: PubMed
  175. Kleiman RB, Miller JM, Buxton AE, Josephson ME, Marchlinski FE. Prognosis following sustained ventricular tachycardia occurring early after myocardial infarction. Am J Cardiol. 1988 Sep 15; 62(9):528-33. PMID: 3414543.
    View in: PubMed
  176. Marchlinski FE, Buxton AE, Kindwall KE, Miller JM, Rosenthal ME, Gottlieb CD, Bloom RB, Josephson ME. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias. Circulation. 1988 Sep; 78(3):583-91. PMID: 3409498.
    View in: PubMed
  177. Schmitt C, Kadish AH, Balke WC, Turk K, Buxton AE, Josephson ME, Marchlinski FE. Cycle length-dependent effects on normal and abnormal intraventricular electrograms: effect of procainamide. J Am Coll Cardiol. 1988 Aug; 12(2):395-403. PMID: 3392333.
    View in: PubMed
  178. Schmitt CG, Kadish AH, Marchlinski FE, Miller JM, Buxton AE, Josephson ME. Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm. Circulation. 1988 May; 77(5):1030-7. PMID: 3359584.
    View in: PubMed
  179. Miller JM, Marchlinski FE, Buxton AE, Josephson ME. Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease. Circulation. 1988 Apr; 77(4):759-66. PMID: 3349580.
    View in: PubMed
  180. Almendral JM, Gottlieb CD, Rosenthal ME, Stamato NJ, Buxton AE, Marchlinski FE, Miller JM, Josephson ME. Entrainment of ventricular tachycardia: explanation for surface electrocardiographic phenomena by analysis of electrograms recorded within the tachycardia circuit. Circulation. 1988 Mar; 77(3):569-80. PMID: 3342488.
    View in: PubMed
  181. Josephson ME, Miller JM, Marchlinski FE, Buxton AE. Nonpharmacologic therapy of ventricular tachycardia. Clin Cardiol. 1988 Mar; 11(3 Suppl 2):II17-21. PMID: 3271190.
    View in: PubMed
  182. Buxton AE, Britton N, Simson MB. Application of the signal-averaged electrocardiogram in patients with nonsustained ventricular tachycardia after myocardial infarction: implications for prediction of sudden cardiac death risk. J Electrocardiol. 1988; 21 Suppl:S40-5. PMID: 3216176.
    View in: PubMed
  183. Marchlinski FE, Buxton AE, Miller JM, Josephson ME. Prevention of ventricular tachycardia induction during right ventricular programmed stimulation by high current strength pacing at the site of origin. Circulation. 1987 Aug; 76(2):332-42. PMID: 3608121.
    View in: PubMed
  184. Kadish AH, Buxton AE, Waxman HL, Flores B, Josephson ME, Marchlinski FE. Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. J Am Coll Cardiol. 1987 Jul; 10(1):90-6. PMID: 3598000.
    View in: PubMed
  185. Buxton AE, Simson MB, Falcone RA, Marchlinski FE, Doherty JU, Josephson ME. Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction. Am J Cardiol. 1987 Jul 01; 60(1):80-5. PMID: 3604948.
    View in: PubMed
  186. Buxton AE, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Circulation. 1987 Jun; 75(6):1178-85. PMID: 3568327.
    View in: PubMed
  187. Buxton AE, Marchlinski FE, Doherty JU, Flores B, Josephson ME. Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol. 1987 May 01; 59(12):1107-10. PMID: 3578051.
    View in: PubMed
  188. Josephson ME, Almendral JM, Buxton AE, Marchlinski FE. Mechanisms of ventricular tachycardia. Circulation. 1987 Apr; 75(4 Pt 2):III41-7. PMID: 3829361.
    View in: PubMed
  189. Kadish AH, Marchlinski FE, Josephson ME, Buxton AE. Amiodarone: correlation of early and late electrophysiologic studies with outcome. Am Heart J. 1986 Dec; 112(6):1134-40. PMID: 3788759.
    View in: PubMed
  190. Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, Josephson ME. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. Circulation. 1986 Nov; 74(5):1037-43. PMID: 3769163.
    View in: PubMed
  191. Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol. 1986 Nov 01; 58(10):992-7. PMID: 3776856.
    View in: PubMed
  192. Rosenthal ME, Stamato NJ, Almendral JM, Marchlinski FE, Buxton AE, Miller JM, Josephson ME. Influence of the site of stimulation on the resetting phenomenon in ventricular tachycardia. Am J Cardiol. 1986 Nov 01; 58(10):970-6. PMID: 3776853.
    View in: PubMed
  193. Vassallo JA, Cassidy DM, Marchlinski FE, Miller JM, Buxton AE, Josephson ME. Abnormalities of endocardial activation pattern in patients with previous healed myocardial infarction and ventricular tachycardia. Am J Cardiol. 1986 Sep 01; 58(6):479-84. PMID: 3751912.
    View in: PubMed
  194. Almendral JM, Rosenthal ME, Stamato NJ, Marchlinski FE, Buxton AE, Frame LH, Miller JM, Josephson ME. Analysis of the resetting phenomenon in sustained uniform ventricular tachycardia: incidence and relation to termination. J Am Coll Cardiol. 1986 Aug; 8(2):294-300. PMID: 3734253.
    View in: PubMed
  195. Kienzle MG, Doherty JU, Cassidy D, Buxton AE, Marchlinski FE, Waxman HL, Josephson ME. Electrophysiologic sequelae of chronic myocardial infarction: local refractoriness and electrographic characteristics of the left ventricle. Am J Cardiol. 1986 Jul 01; 58(1):63-9. PMID: 3728333.
    View in: PubMed
  196. Vassallo JA, Cassidy DM, Miller JM, Buxton AE, Marchlinski FE, Josephson ME. Left ventricular endocardial activation during right ventricular pacing: effect of underlying heart disease. J Am Coll Cardiol. 1986 Jun; 7(6):1228-33. PMID: 3711479.
    View in: PubMed
  197. Buxton AE. Sudden cardiac death--1986. Ann Intern Med. 1986 May; 104(5):716-8. PMID: 3963667.
    View in: PubMed
  198. Cassidy DM, Vassallo JA, Miller JM, Poll DS, Buxton AE, Marchlinski FE, Josephson ME. Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Circulation. 1986 Apr; 73(4):645-52. PMID: 3948367.
    View in: PubMed
  199. Marchlinski FE, Flores BT, Buxton AE, Hargrove WC, Addonizio VP, Stephenson LW, Harken AH, Doherty JU, Grogan EW, Josephson ME. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures. Ann Intern Med. 1986 Apr; 104(4):481-8. PMID: 3954276.
    View in: PubMed
  200. Buxton AE, Josephson ME. Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs. Circulation. 1986 Feb; 73(2 Pt 2):II67-72. PMID: 3943175.
    View in: PubMed
  201. Eysmann SB, Marchlinski FE, Buxton AE, Josephson ME. Electrocardiographic changes after cardioversion of ventricular arrhythmias. Circulation. 1986 Jan; 73(1):73-81. PMID: 3940671.
    View in: PubMed
  202. Almendral JM, Gottlieb C, Marchlinski FE, Buxton AE, Doherty JU, Josephson ME. Entrainment of ventricular tachycardia by atrial depolarizations. Am J Cardiol. 1985 Aug 01; 56(4):298-304. PMID: 4025169.
    View in: PubMed
  203. Vassallo JA, Cassidy D, Simson MB, Buxton AE, Marchlinski FE, Josephson ME. Relation of late potentials to site of origin of ventricular tachycardia associated with coronary heart disease. Am J Cardiol. 1985 Apr 01; 55(8):985-9. PMID: 3984886.
    View in: PubMed
  204. Marchlinski FE, Buxton AE, Flores BT, Doherty JU, Waxman HL, Josephson ME. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. Am J Cardiol. 1985 Mar 01; 55(6):709-12. PMID: 3976513.
    View in: PubMed
  205. Doherty JU, Pembrook-Rogers D, Grogan EW, Falcone RA, Buxton AE, Marchlinski FE, Cassidy DM, Kienzle MG, Almendral JM, Josephson ME. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol. 1985 Mar 01; 55(6):703-8. PMID: 3976512.
    View in: PubMed
  206. Cassidy DM, Vassallo JA, Buxton AE, Doherty JU, Marchlinski FE, Josephson ME. Catheter mapping during sinus rhythm: relation of local electrogram duration to ventricular tachycardia cycle length. Am J Cardiol. 1985 Mar 01; 55(6):713-6. PMID: 3976514.
    View in: PubMed
  207. Buxton AE, Marchlinski FE, Doherty JU, Waxman HL, Josephson ME. Mechanism of lethal arrhythmias: results of programmed electrical stimulation. Cardiovasc Clin. 1985; 15(3):155-61. PMID: 3833365.
    View in: PubMed
  208. Marchlinski FE, Buxton AE, Doherty JU, Cassidy DM, Vassallo JA, Miller JM, Kienzle MG, Grogan W, Almendral JM, Waxman HL, et al. Use of programmed electrical stimulation to predict sudden death after myocardial infarction. Cardiovasc Clin. 1985; 15(3):163-9. PMID: 3833366.
    View in: PubMed
  209. Roy D, Marchlinski FE, Doherty JU, Buxton AE, Josephson ME. Pharmacologic therapy for survivors of sudden death based on programmed stimulation. Cardiovasc Clin. 1985; 15(3):179-85. PMID: 3914364.
    View in: PubMed
  210. Roy D, Marchlinski FE, Doherty JU, Buxton AE, Waxman HL, Josephson ME. Electrophysiologic testing of survivors of cardiac arrest. Cardiovasc Clin. 1985; 15(3):171-7. PMID: 3833367.
    View in: PubMed
  211. Buxton AE. The use of multiple extrastimuli during programmed ventricular stimulation: how many should be used? Int J Cardiol. 1985 Jan; 7(1):86-91. PMID: 4055141.
    View in: PubMed
  212. Marchlinski FE, Buxton AE, Vassallo JA, Waxman HL, Cassidy DM, Doherty JU, Josephson ME. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias. J Am Coll Cardiol. 1984 Dec; 4(6):1247-54. PMID: 6209319.
    View in: PubMed
  213. Buxton AE, Josephson ME. Sudden cardiac death--a perspective. West J Med. 1984 Nov; 141(5):677-9. PMID: 6516339; PMCID: PMC1011184.
  214. Almendral JM, Grogan EW, Cassidy DM, Vassallo JA, Marchlinski FE, Buxton AE, Doherty JU, Josephson ME. Timing of the right ventricular apical electrogram during sustained ventricular tachycardia: relation to surface QRS morphology and potential clinical implications. Am J Cardiol. 1984 Nov 01; 54(8):1003-7. PMID: 6496320.
    View in: PubMed
  215. Buxton AE, Marchlinski FE, Doherty JU, Cassidy DM, Vassallo JA, Flores BT, Josephson ME. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease. Am J Cardiol. 1984 Nov 01; 54(8):997-1002. PMID: 6496364.
    View in: PubMed
  216. Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol. 1984 Oct 01; 54(7):755-61. PMID: 6486024.
    View in: PubMed
  217. Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation. 1984 Sep; 70(3):451-6. PMID: 6744550.
    View in: PubMed
  218. Waxman HL, Buxton AE, Marchlinski FE, Harken AH, Josephson ME. Medical versus surgical treatment of tachydysrhythmias. Eur Heart J. 1984 Sep; 5 Suppl B:103-8. PMID: 6499867.
    View in: PubMed
  219. Doherty JU, Kienzle MG, Buxton AE, Marchlinski FE, Waxman HL, Josephson ME. Discordant results of programmed ventricular stimulation at different right ventricular sites in patients with and without spontaneous sustained ventricular tachycardia: a prospective study of 56 patients. Am J Cardiol. 1984 Aug 01; 54(3):336-42. PMID: 6465014.
    View in: PubMed
  220. Doherty JU, Waxman HL, Kienzle MG, Cassidy DM, Marchlinski FE, Buxton AE, Josephson ME. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. J Am Coll Cardiol. 1984 Aug; 4(2):378-81. PMID: 6736479.
    View in: PubMed
  221. Cassidy DM, Vassallo JA, Marchlinski FE, Buxton AE, Untereker WJ, Josephson ME. Endocardial mapping in humans in sinus rhythm with normal left ventricles: activation patterns and characteristics of electrograms. Circulation. 1984 Jul; 70(1):37-42. PMID: 6723010.
    View in: PubMed
  222. Cassidy DM, Vassallo JA, Buxton AE, Doherty JU, Marchlinski FE, Josephson ME. The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia. Circulation. 1984 Jun; 69(6):1103-10. PMID: 6713614.
    View in: PubMed
  223. Marchlinski FE, Buxton AE, Waxman HL, Josephson ME. Electrophysiologic effects of intravenous metoprolol. Am Heart J. 1984 Jun; 107(6):1125-31. PMID: 6720539.
    View in: PubMed
  224. Vassallo JA, Cassidy DM, Marchlinski FE, Buxton AE, Waxman HL, Doherty JU, Josephson ME. Endocardial activation of left bundle branch block. Circulation. 1984 May; 69(5):914-23. PMID: 6705167.
    View in: PubMed
  225. Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME. Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol. 1984 May 01; 53(9):1275-9. PMID: 6711427.
    View in: PubMed
  226. Lerman BB, Marchlinski FE, Kempf FC, Buxton AE, Waxman HL, Josephson ME. Prognosis in patients with intra-Hisian conduction disturbances. Int J Cardiol. 1984 Apr; 5(4):449-60. PMID: 6724746.
    View in: PubMed
  227. Buxton AE, Waxman HL, Marchlinski FE, Untereker WJ, Waspe LE, Josephson ME. Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. Circulation. 1984 Mar; 69(3):532-40. PMID: 6692515.
    View in: PubMed
  228. Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol. Am J Cardiol. 1984 Mar 01; 53(6):738-44. PMID: 6702622.
    View in: PubMed
  229. Buxton AE, Josephson ME. Ventricular tachycardia--1983. Pacing Clin Electrophysiol. 1984 Jan; 7(1):96-108. PMID: 6199777.
    View in: PubMed
  230. Marchlinski FE, Buxton AE, Waxman HL, Josephson ME. Identifying patients at risk of sudden death after myocardial infarction: value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction. Am J Cardiol. 1983 Dec 01; 52(10):1190-6. PMID: 6650407.
    View in: PubMed
  231. Doherty JU, Kienzle MG, Waxman HL, Buxton AE, Marchlinski FE, Josephson ME. Programmed ventricular stimulation at a second right ventricular site: an analysis of 100 patients, with special reference to sensitivity, specificity and characteristics of patients with induced ventricular tachycardia. Am J Cardiol. 1983 Dec 01; 52(10):1184-9. PMID: 6650406.
    View in: PubMed
  232. Roy D, Waxman HL, Kienzle MG, Buxton AE, Marchlinski FE, Josephson ME. Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. Am J Cardiol. 1983 Nov 01; 52(8):969-74. PMID: 6637850.
    View in: PubMed
  233. Buxton AE, Waxman HL, Marchlinski FE, Simson MB, Cassidy D, Josephson ME. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation. 1983 Nov; 68(5):917-27. PMID: 6137291.
    View in: PubMed
  234. Lerman BB, Waxman HL, Buxton AE, Sweeney M, Josephson ME. Tachyarrhythmias associated with programmable automatic atrial antitachycardia pacemakers. Am Heart J. 1983 Nov; 106(5 Pt 1):1029-35. PMID: 6688920.
    View in: PubMed
  235. Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Electrophysiologic studies in nonsustained ventricular tachycardia: relation to underlying heart disease. Am J Cardiol. 1983 Nov 01; 52(8):985-91. PMID: 6685428.
    View in: PubMed
  236. Ezri M, Lerman BB, Marchlinski FE, Buxton AE, Josephson ME. Electrophysiologic evaluation of syncope in patients with bifascicular block. Am Heart J. 1983 Oct; 106(4 Pt 1):693-7. PMID: 6613815.
    View in: PubMed
  237. Marchlinski FE, Waxman HL, Buxton AE, Josephson ME. Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival. J Am Coll Cardiol. 1983 Aug; 2(2):240-50. PMID: 6863760.
    View in: PubMed
  238. Doherty JU, Kienzle MG, Waxman HL, Buxton AE, Marchlinski FE, Josephson ME. Relation of mode of induction and cycle length of ventricular tachycardia: analysis of 104 patients. Am J Cardiol. 1983 Jul; 52(1):60-4. PMID: 6858928.
    View in: PubMed
  239. Ezri MD, Marchlinski FE, Buxton AE, Waxman HL, Josephson ME. Electrophysiologic effects of intravenous timolol. Int J Cardiol. 1983 Jun; 3(3):329-37. PMID: 6874146.
    View in: PubMed
  240. Roy D, Waxman HL, Buxton AE, Josephson ME. Horizontal and longitudinal dissociation of the A-V node during atrial tachycardia. Pacing Clin Electrophysiol. 1983 May; 6(3 Pt 1):569-76. PMID: 6191294.
    View in: PubMed
  241. Waspe LE, Waxman HL, Buxton AE, Josephson ME. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients. Am J Cardiol. 1983 Apr; 51(7):1175-81. PMID: 6340451.
    View in: PubMed
  242. Lerman BB, Waxman HL, Buxton AE, Josephson ME. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol. 1983 Mar 01; 51(5):759-64. PMID: 6829435.
    View in: PubMed
  243. Waxman HL, Buxton AE, Sadowski LM, Josephson ME. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. Circulation. 1983 Jan; 67(1):30-7. PMID: 6847803.
    View in: PubMed
  244. Gardner MJ, Waxman HL, Buxton AE, Cain ME, Josephson ME. Termination of ventricular tachycardia. Evaluation of a new pacing method. Am J Cardiol. 1982 Dec; 50(6):1338-45. PMID: 7148711.
    View in: PubMed
  245. Roy D, Waxman HL, Buxton AE, Marchlinski FE, Cain ME, Gardner MJ, Josephson ME. Termination of ventricular tachycardia: role of tachycardia cycle length. Am J Cardiol. 1982 Dec; 50(6):1346-50. PMID: 7148712.
    View in: PubMed
  246. Waxman HL, Groh WC, Marchlinski FE, Buxton AE, Sadowski LM, Horowitz LN, Josephson ME, Kastor JA. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. Am J Cardiol. 1982 Nov; 50(5):1066-74. PMID: 6291368.
    View in: PubMed
  247. Buxton AE, Hirshfeld JW, Untereker WJ, Goldberg S, Harken AH, Stephenson LW, Edie RN. Perioperative coronary arterial spasm: long-term follow-up. Am J Cardiol. 1982 Sep; 50(3):444-51. PMID: 6810684.
    View in: PubMed
  248. Josephson ME, Waxman HL, Cain ME, Gardner MJ, Buxton AE. Ventricular activation during ventricular endocardial pacing. II. Role of pace-mapping to localize origin of ventricular tachycardia. Am J Cardiol. 1982 Jul; 50(1):11-22. PMID: 7090993.
    View in: PubMed
  249. Buxton AE, Josephson ME. The role of P wave duration as a predictor of postoperative atrial arrhythmias. Chest. 1981 Jul; 80(1):68-73. PMID: 6972856.
    View in: PubMed
  250. Buxton AE, Goldberg S, Harken A, Hirshfield J, Kastor JA. Coronary-artery spasm immediately after myocardial revascularization: recognition and management. N Engl J Med. 1981 May 21; 304(21):1249-53. PMID: 6783907.
    View in: PubMed
  251. Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, Overlie P, Oliva P. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol. 1980 Aug; 46(2):329-34. PMID: 6773407.
    View in: PubMed
  252. Buxton AE, Highsmith AK, Garner JS, West CM, Stamm WE, Dixon RE, McGowan JE. Contamination of intravenous infusion fluid: effects of changing administration sets. Ann Intern Med. 1979 May; 90(5):764-8. PMID: 373560.
    View in: PubMed
  253. Buxton AE, Morganroth J, Josephson ME, Perloff JK, Shelburne JC. Isolated dextroversion of the heart with asymmetric septal hypertrophy. Am Heart J. 1976 Dec; 92(6):785-90. PMID: 136888.
    View in: PubMed
  254. Ryder RW, Wachsmuth IK, Buxton AE, Evans DG, DuPont HL, Mason E, Barrett FF. Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med. 1976 Oct 14; 295(16):849-53. PMID: 785259.
    View in: PubMed
  255. Buxton AE, Meyers JD, Gardner LB. Attention: a case of Munchausen syndrome. Ann Intern Med. 1972 Sep; 77(3):477. PMID: 5053738.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Buxton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (412)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.